Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

FDA clears IND application for ACH-5228

Nov. 12, 2019

FDA approves Reblozyl for anemia in beta thalassemia requiring regular RBC transfusions

Nov. 11, 2019

UMC Utrecht Holding discloses thombolytic fusion proteins

Nov. 11, 2019

Pfizer initiates phase III study of PF-06741086

Nov. 11, 2019

New milestones announced for hematology product candidate AXA-4010

Nov. 7, 2019

Initiation of phase Ib study of mavorixafor in severe congenital neutropenia

Nov. 6, 2019

First patient dosed in phase II study of novel hepcidin mimetic PTG-300

Oct. 31, 2019

BioCryst advances phase I study of BCX-9930 for paroxysmal nocturnal hemoglobinuria

Oct. 29, 2019

Grant supports clinical trial of personalized treatment approach for aplastic anemia

Oct. 23, 2019

Ultomiris approved in U.S. for atypical hemolytic uremic syndrome

Oct. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....